Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung ...

Sanofi SA (NASDAQ:SASY) has announced an agreement in principle to settle approximately 4,000 lawsuits ... that Zantac, manufactured by Sanofi and other companies, may have caused cancer due ...

Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. November 22 ...

Carrie Joiner had claimed in her lawsuit that she developed colorectal cancer from a contaminant known as NDMA found in GSK's heartburn medication Zantac ... of times an ad is presented to ...

GSK claims to investors that its decision to remove Zantac ... of cancer in patients." The Company admitted it could not "quantify or reliably estimate the liability" it would face from lawsuits ...

GSK’s shares rose by as much as 6.5% on Thursday before settling back slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now ...

who did not know that GSK had for decades concealed an internal study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors ...

While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer ... What Is The Lawsuit About? The complaint filed in this class action ...

Cruz announces that a class action lawsuit has been filed on behalf ... research did not support a correlation between Zantac and cancer, the Deutsche Bank report stated that the total liability ...